Dixon Mitchell Investment Counsel’s Eli Lilly LLY Stock Holding History

Dixon Mitchell Investment Counsel’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$327K	Sell	273 -135	-33%	-$138K	0.01%	71
2026 Q1	$375K	Hold	408	–	–	0.01%	65
2025 Q4	$438K	Buy	+408	New	+$390K	0.01%	58
2025 Q2	–	Sell	-9	Closed	-$7.43K	–	91
2025 Q1	$7.43K	Hold	9	–	–	﹤0.01%	79
2024 Q4	$6.95K	Buy	+9	New	+$7.45K	﹤0.01%	97
2015 Q3	–	Sell	-2,400	Closed	-$200K	–	67
2015 Q2	$200K	Buy	+2,400	New	+$183K	0.03%	66
2014 Q3	–	Sell	-29,040	Closed	-$1.81M	–	65
2014 Q2	$1.81M	Sell	29,040 -3,670	-11%	-$219K	0.26%	56
2014 Q1	$1.93M	Buy	32,710 +890	+3%	+$49.7K	0.3%	55
2013 Q4	$1.62M	Buy	31,820 +1,820	+6%	+$91.1K	0.26%	56
2013 Q3	$1.51M	Sell	30,000 -760	-2%	-$39.8K	0.26%	57
2013 Q2	$1.51M	Buy	+30,760	New	+$1.67M	0.28%	53

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dixon Mitchell Investment Counsel's LLY Position: Q2 2026 in Review

Dixon Mitchell Investment Counsel reduced its Eli Lilly (LLY) stake by 33% in Q2 2026, selling an estimated $138K and leaving 273 shares worth $327K. The position accounts for 0.01% of the portfolio, ranked #71.

Dixon Mitchell Investment Counsel first reported a position in LLY in Q2 2013 and has held it in 11 quarters since. The position peaked at $1.93M in Q1 2014. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Dixon Mitchell Investment Counsel held 273 shares of Eli Lilly worth $327K as of Q2 2026.
Dixon Mitchell Investment Counsel sold 135 Eli Lilly shares in Q2 2026, an estimated $138K.
Eli Lilly made up 0.01% of Dixon Mitchell Investment Counsel's portfolio in Q2 2026, its #71 holding.
Dixon Mitchell Investment Counsel first reported a position in Eli Lilly in Q2 2013 and has held it in 11 quarters since.
Dixon Mitchell Investment Counsel's Eli Lilly position peaked at $1.93M in Q1 2014.
4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Dixon Mitchell Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.